Search results
AbbVie Inc. (NYSE:ABBV) Shares Sold by First Hawaiian Bank
ETF DAILY NEWS· 2 days agoFirst Hawaiian Bank cut its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 10.2% in the first quarter, Holdings Channel.com reports. The fund owned 29,442 shares ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Garde Capital Inc.
ETF DAILY NEWS· 7 days agoGarde Capital Inc. lowered its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 60.8% in the fourth quarter, according to the company in its most recent disclosure with ...
As AbbVie Drug Gets FDA Nod, Traders Can Look Up to These Targets
TheStreet.com· 2 days agoAbbVie (ABBV) on Wednesday won Food and Drug Administration approval for a new use for its drug...
AbbVie Inc. (NYSE:ABBV) Holdings Cut by Carolina Wealth Advisors LLC
ETF DAILY NEWS· 2 days agoCarolina Wealth Advisors LLC decreased its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 5.2% during the 1st quarter, according to its most recent filing ...
AbbVie (NYSE:ABBV) Given New $190.00 Price Target at Piper Sandler
ETF DAILY NEWS· 4 days agoAbbVie (NYSE:ABBV – Get Free Report) had its price objective boosted by research analysts at Piper Sandler from $185.00 to $190.00 in a research note issued on Tuesday, Benzinga ...
239 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Ables Iannone Moore & Associates Inc.
ETF DAILY NEWS· 4 days agoAbles Iannone Moore & Associates Inc. bought a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent disclosure ...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 3 days agoAbbVie ABBV announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat...
AbbVie says FDA approves Skyrizi for ulcerative colitis
Market Watch· 3 days agoDrug maker AbbVie Inc. on Tuesday said the Food and Drug Administration had approved its drug...
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 3 days agoThe latest trading session saw AbbVie (ABBV) ending at $171.36, denoting a +0.99% adjustment from...
Beese Fulmer Investment Management Inc. Cuts Stock Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 2 days agoBeese Fulmer Investment Management Inc. reduced its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.6% during the first quarter, Holdings Channel.com reports. The institutional ...